Compare UTMD & WIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UTMD | WIA |
|---|---|---|
| Founded | 1978 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.5M | 189.4M |
| IPO Year | 1994 | N/A |
| Metric | UTMD | WIA |
|---|---|---|
| Price | $63.80 | $8.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.4K | ★ 56.2K |
| Earning Date | 04-23-2026 | 01-01-0001 |
| Dividend Yield | 1.91% | ★ 12.29% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $38,520,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $78.01 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $52.00 | $7.95 |
| 52 Week High | $71.81 | $8.54 |
| Indicator | UTMD | WIA |
|---|---|---|
| Relative Strength Index (RSI) | 38.48 | 47.96 |
| Support Level | $60.23 | $8.07 |
| Resistance Level | $64.21 | $8.24 |
| Average True Range (ATR) | 1.42 | 0.06 |
| MACD | -0.36 | 0.00 |
| Stochastic Oscillator | 16.39 | 43.75 |
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.